D014635Chemicals & DrugsD02.241.081.944.509.900D10.251.400.895.593.90017240.984361Valproic AcidFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonDouglasNordliDouglas Nordli41.7886000000000087.598699999999993714Nordli, DouglasProfessorMedicine-Hematology and OncologyPediatrics-Hematology and OncologyTabraizMohammedTabraiz Mohammed41.7886000000000087.598699999999993996Mohammed, TabraizClinical Associate22863973Gu S, Tian Y, Chlenski A, Salwen HR, Lu Z, Raj JU, Yang QAnti-cancer drugsValproic acid shows a potent antitumor effect with alteration of DNA methylation in neuroblastoma. Anticancer Drugs. 2012 Nov; 23(10):1054-66.Anticancer Drugs2012-11-01T00:00:002012Valproic acid shows a potent antitumor effect with alteration of DNA methylation in neuroblastoma.0.8322360.016216917research area of0.5484650.021362124subject area forPediatricsUniversity of Chicago21632454Mohammed TA, Holen KD, Jaskula-Sztul R, Mulkerin D, Lubner SJ, Schelman WR, Eickhoff J, Chen H, Loconte NKThe oncologistA pilot phase II study of valproic acid for treatment of low-grade neuroendocrine carcinoma. Oncologist. 2011; 16(6):835-43.Oncologist2011-05-31T00:00:002011A pilot phase II study of valproic acid for treatment of low-grade neuroendocrine carcinoma.AbhinavSidanaAbhinav Sidana41.7886000000000087.598699999999994460Sidana, AbhinavAssociate Professor23093837Sidana A, Wang M, Shabbeer S, Chowdhury WH, Netto G, Lupold SE, Carducci M, Rodriguez RJournal of biomedicine & biotechnologyMechanism of growth inhibition of prostate cancer xenografts by valproic acid. J Biomed Biotechnol. 2012; 2012:180363.J Biomed Biotechnol2012-10-02T00:00:002012Mechanism of growth inhibition of prostate cancer xenografts by valproic acid.EmilCoccaroEmil F. Coccaro41.78927490000000-87.601250000000001632Coccaro, EmilProfessorAlexandreChlenskiAlexandre Chlenski41.78927490000000-87.60125000000000610Chlenski, AlexandreResearch Associate Professortrue1Clinical AssociateClinical Associatetrue1ProfessorProfessortrue1Research Associate ProfessorResearch Associate Professortrue1ProfessorProfessortrue1Associate ProfessorAssociate Professor1010Surgery-UrologyPsychiatry & Behav. Neurosci26277033Coccaro EF, Lee R, Breen EC, Irwin MRPsychiatry researchInflammatory markers and chronic exposure to fluoxetine, divalproex, and placebo in intermittent explosive disorder. Psychiatry Res. 2015 Oct 30; 229(3):844-9.Psychiatry Res2015-07-29T00:00:002015Inflammatory markers and chronic exposure to fluoxetine, divalproex, and placebo in intermittent explosive disorder.23380105Bakhshayesh B, Seyed Saadat SM, Rezania K, Hatamian H, Hossieninezhad MThe American journal of emergency medicineA randomized open-label study of sodium valproate vs sumatriptan and metoclopramide for prolonged migraine headache. Am J Emerg Med. 2013 Mar; 31(3):540-4.Am J Emerg Med2013-02-04T00:00:002013A randomized open-label study of sodium valproate vs sumatriptan and metoclopramide for prolonged migraine headache.